Alteration of plasma prednisolone levels by indomethacin and naproxen.
Eleven patients with stable rheumatoid disease (RD) who were receiving regular corticosteroid therapy (CS) were investigated to discover the effect on plasma prednisolone levels of additional therapy with the non-steroidal anti-inflammatory (NSAI) drugs, indomethacin and naproxen. There was a highly significant (P less than 0.001) increase in free prednisolone levels after concurrent therapy with either indomethacin or naproxen for 2 weeks. Total prednisolone levels were unchanged. These results could provide an explanation for clinical reports that these two NSAI drugs possess a steroid-sparing effect.
D000368:Aged; D005260:Female; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged; D009288:Naproxen / Q000494:pharmacology*; D011239:Prednisolone / Q000097:blood*; D011485:Protein Binding
D009288:Naproxen; D011239:Prednisolone; D007213:Indomethacin